Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study | Zendy

Adel Gabriel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study

Author(s) -

Adel Gabriel

Publication year - 2010

Publication title -

neuropsychiatric disease and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.819

H-Index - 67

eISSN - 1178-2021

pISSN - 1176-6328

DOI - 10.2147/ndt.s13407

Subject(s) - medicine , olanzapine , risperidone , gabapentin , schizophrenia (object oriented programming) , open label , adjunctive treatment , pharmacology , psychiatry , adverse effect , alternative medicine , pathology

There is a great need in the treatment of schizophrenia for a drug, or drug combinations, to improve clinical response with fewer serious side effects. The objective of this study was to explore the therapeutic effects and tolerability of the anticonvulsant gabapentin as an adjunctive in the treatment of patients with partially responsive schizophrenia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research